Pfizer (PFE) Non Operating Income (2010 - 2012)

Pfizer (PFE) has reported Non Operating Income for 3 consecutive years, with $293.0 million the latest figure, recorded in Q3 2012.

• In Q3 2012, Non Operating Income rose 2.09% year-over-year to $293.0 million; the TTM figure through Jul 2012 stood at $1.2 billion (down 10.3% YoY), while the FY2011 annual figure was $1.2 billion, down 12.33% from the prior year.
• Non Operating Income declined to $293.0 million in Q3 2012 per PFE's latest filing, from $309.0 million in the prior quarter.
• Across five years, Non Operating Income topped out at $410.0 million in Q2 2010 and bottomed at $270.0 million in Q4 2011.
• Historically, Non Operating Income has averaged $322.0 million across 3 years, with a median of $311.0 million in 2011.
• Annual changes were most pronounced in 2011 — Non Operating Income dropped 23.73% — and 2012, when it grew 2.09%.
• Pfizer's Non Operating Income stood at $354.0 million in 2010, then retreated by 23.73% to $270.0 million in 2011, then advanced by 8.52% to $293.0 million in 2012.
• Business Quant data shows PFE's Non Operating Income at $293.0 million in Q3 2012, $309.0 million in Q2 2012, and $270.0 million in Q4 2011.